RedHill Biopharma Ltd.

2.79
0.04 (1.45%)
At close: Mar 28, 2025, 3:56 PM
2.70
-3.23%
After-hours: Mar 28, 2025, 07:58 PM EDT

RedHill Biopharma Ltd. Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
PE Ratio 0.02 -0.01 -0.07 -0.21 -0.26 -0.2 -0.12 -0.28 -0.42 -0.67 -0.43 -0.27 -0.17 -1.11
PEG Ratio -0.00 0.00 -0.12 -0.00 0.02 0.01 -0.01 -0.01 -0.01 0.02 0.03 0.01 -0.00 n/a
PS Ratio 0.09 0.01 0.09 0.29 1.79 0.95 1.40 80.08 2.97K 1.03 383.37 173.44 112.38 n/a
PB Ratio 0.29 -0.01 0.85 1.33 0.19 0.15 0.12 0.13 0.15 0.29 0.39 0.15 0.14 n/a
P/FCF Ratio -0.02 -0.02 -0.12 -0.18 -0.28 -0.23 -0.12 -0.29 -0.46 -0.54 -0.53 -0.4 -0.53 -1.03
P/OCF Ratio -0.02 -0.02 -0.12 -0.38 -0.28 -0.23 -0.13 -0.29 -0.5 -0.59 -0.55 -0.41 -0.55 -1.73
OCF/S Ratio -5.5 -0.47 -0.76 -0.75 -6.48 -4.12 -11.17 -279.78 -5.94K -1.74 -703 -424.69 -203.96 n/a
Debt / Equity Ratio 0.57 -2.53 9.89 6.27 0.06 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Quick Ratio 0.61 0.38 0.91 0.87 4.84 5.40 4.31 12.45 17.23 23.87 5.37 18.10 39.43 n/a
Current Ratio 0.84 0.44 1.09 0.96 5.01 5.47 4.37 12.66 10.97 15.13 5.22 17.22 36.52 n/a
Asset Turnover 0.28 0.39 0.47 0.36 0.08 0.13 0.07 0.00 0.00 0.24 0.00 0.00 0.00 n/a
Interest Coverage 34.42 -1.04 -4.9 -4.99 -98.63 -235.51 -674.96 -81.45 -103.78 -27.8 -769.43 -6.1 -121.12 -1.98
Return on Equity (ROE) 11.56 1.22 -12.88 -6.42 -0.73 -0.76 -1.01 -0.47 -0.35 -0.43 -0.89 -0.54 -0.83 n/a
Return on Assets (ROA) 1.04 -0.37 -0.63 -0.49 -0.59 -0.62 -0.79 -0.4 -0.32 -0.37 -0.74 -0.51 -0.77 n/a
Return on Capital (ROIC) 3.32 1.11 -0.81 -0.6 -0.68 -0.76 -1.14 -0.44 -0.36 -0.39 -0.9 -0.48 -0.4 n/a
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 46.89% 46.06% 42.39% 42.68% 64.09% 66.06% 46.94% -30.14K% -733.3K% 85.03% 100.00% 100.00% 100.00% n/a
Net Profit Margin 367.19% -95.87% -133.3% -138.31% -693.59% -464.35% -1.14K% -29.08K% -703K% -152.71% -88.57K% -64.54K% -67.4K% n/a
Pretax Profit Margin 367.75% -115.97% -113.98% -118.36% -672.45% -464.35% -1.14K% -29.08K% -703K% -152.71% -88.57K% -64.54K% -67.4K% n/a
Operating Profit Margin 193.95% -69.33% -94.61% -98.95% -686.71% -470.47% -1.3K% -30.24K% -733.4K% -151.8% -89.77K% -56.5K% -34.23K% n/a
FCF Margin -550.13% -47.55% -75.98% -159.03% -650.96% -412.92% -1.15K% -28.1K% -648.67K% -190.11% -72.17K% -43.14K% -21.18K% n/a
EBITDA Margin 403.94% -69.33% -73.5% -85.36% -648.3% -461.77% -1.14K% -30.2K% -728.87K% -151.41% -89.57K% -56.35K% -34.17K% n/a